Webinar | July 19, 2016

Webinar: Exploring the Prevalence of Motion Artifacts in Clinical MRI and Possible Solution Strategies

This webinar is part of the DAIC Webinar Series and is supported by an educational grant from Philips Healthcare

This webinar explains the prevalence of MRI motion artifacts, outline the related financial and time burdens associated with patient motion and summarize solutions. The speaker is Jalal Andre, M.D., director of neurological MRI, radiology, at Harborview Medical Center and an assistant professor at the University of Washington, Seattle. 


The webinar took place July 27, 2016.


Register for the archive version of this webinar


 


Statement of Purpose/Need:


This webinar will explain the prevalence of MRI motion artifacts, outline the related financial and time burdens associated with patient motion and summarize solutions. 

 


Learning Objectives:


Upon completion of this activity, participants will be able to:


• Describe the prevalence of motion artifacts in a clinical population that can vary based on patient disposition and scanner parameters.

• Identify the financial and temporal opportunity costs associated with patient motion.

• Outline possible solution strategies to mitigate patient motion during clinical MRI scanning.


 


Intended Audience:


This webinar is intended for radiologists and MRI technologists.

 


Presenters:


Jalal B. Andre, M.D.

Assistant Professor, Radiology

University of Washington

Director of Neurological MRI, Radiology

Harborview Medical Center

Seattle, WA


Andre is director of neurological MRI and is the MRI safety officer at Harborview Medical Center in Seattle. He also serves as an assistant professor of radiology, with expertise in neuroradiology, at the University of Washington. His research interests include the clinical application of advanced MRI techniques in assessing brain vessel abnormalities and traumatic brain injury. Specifically, Andre’s focus involves measuring brain perfusion using arterial spin labeling, an MRI technique that can non-invasively measure blood delivery to the brain and requires no IV contrast. He is also involved in on-going clinical research using this technique to better understand vasospasm, a type of temporary vessel narrowing that can occur in patients with aneurysmal subarachnoid hemorrhage. The technique is also being explored to evaluate sports-related traumatic brain injury in adolescents.


 


Disclosure Information:


Jalal B. Andre, M.D.

Assistant Professor, Radiology

University of Washington

Director of Neurological MRI, Radiology

Harborview Medical Center

Seattle, Wash.


Financial relationships:

None


Discussion of off-label, investigational or experimental drugs/devices use:

Prospective optimized tracking devices


 


Register for the archive version of this webinar


Related Content

MRI May Predict Neurological Outcomes for Cardiac Arrest Survivors
News | Sudden Cardiac Arrest| October 18, 2017
Magnetic resonance imaging (MRI)-based measurements of the functional connections in the brain can help predict long-...
Appropriate Use Criteria Published for Valvular Heart Disease Imaging Tests
News | Clinical Decision Support| October 16, 2017
The American College of Cardiology (ACC), along with several partnering societies, recently released appropriate use...
Dee Dee Wang runs Henry Ford Hospital's 3D printing lab for its complex structural heart cardiology program.

Dee Dee Wang, M.D., runs Henry Ford Hospital's 3-D printing lab that supports its complex structural heart program.

Feature | 3-D Printing| October 13, 2017 | Dave Fornell
Three-dimensional (3-D) printed anatomic models created from a patient’s computed tomography (CT), magnetic resonance...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound| October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
FDA Clears Siemens Magnetom Terra 7T MRI Device

The FDA has cleared the Siemens Magnetom Terra as the first 7T MRI system in the U.S. to gain regulatory approval.

Technology | Magnetic Resonance Imaging (MRI)| October 12, 2017
The U.S. Food and Drug Administration (FDA) cleared the first 7 Tesla (7T) magnetic resonance imaging (MRI) device,...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI)| October 11, 2017
MR Solutions took their cryogen-free preclinical multimodality magnetic resonance imaging (MRI) solutions on tour in...
ACR Appropriateness Criteria Add Topics, Increase Diagnostic Imaging Clinical Scenarios
News | Clinical Decision Support| October 11, 2017
Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR Appropriateness...
Medis Releases QAngio CT v3.1
Technology | Computed Tomography (CT)| October 09, 2017
Medis has released a new version of its QAngio CT (computed tomography), which can now be launched from the Medis Suite...
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD)| September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Overlay Init